Cargando…

Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study

BACKGROUND: With a recent increase in the prevalence of autism spectrum disorder (ASD), an important issue has emerged in clinical practice regarding when and how patients themselves should be given explanations following a diagnosis of ASD. The clinical guidelines of the UK National Institute for H...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Hiroyuki, Fujita, Misao, Tsuchiya, Atsushi, Hatta, Taichi, Mori, Katsumi, Nakazawa, Eisuke, Takimoto, Yoshiyuki, Akabayashi, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391641/
https://www.ncbi.nlm.nih.gov/pubmed/35987775
http://dx.doi.org/10.1186/s13030-022-00247-0
_version_ 1784770893839335424
author Sato, Hiroyuki
Fujita, Misao
Tsuchiya, Atsushi
Hatta, Taichi
Mori, Katsumi
Nakazawa, Eisuke
Takimoto, Yoshiyuki
Akabayashi, Akira
author_facet Sato, Hiroyuki
Fujita, Misao
Tsuchiya, Atsushi
Hatta, Taichi
Mori, Katsumi
Nakazawa, Eisuke
Takimoto, Yoshiyuki
Akabayashi, Akira
author_sort Sato, Hiroyuki
collection PubMed
description BACKGROUND: With a recent increase in the prevalence of autism spectrum disorder (ASD), an important issue has emerged in clinical practice regarding when and how patients themselves should be given explanations following a diagnosis of ASD. The clinical guidelines of the UK National Institute for Health and Care Excellence state that children diagnosed with ASD should receive an explanation about what ASD is and how it affects their development and functioning—“if appropriate”. However, the guidelines do not provide any specifics regarding what constitutes “appropriate” situations METHODS: We conducted an anonymous self-administered postal questionnaire survey targeting all members of the Japanese Society for Child and Adolescent Psychiatry (n=1,995). The analysis included only physicians who had newly diagnosed pediatric patients with ASD in the past year. We imposed a limit of one year because diagnoses further back than that are difficult to recall; in other words, this would enhance the recall bias RESULTS: The recovery rate was 30.8%, and the rate of diagnosis disclosure to patients themselves without intellectual disability was 15.3%. We asked 361 physicians who responded that “deciding on a case-by-case basis” was the ideal way to disclose an ASD diagnosis about 20 items prioritized by physicians at the time of diagnosis disclosure and extracted three factors through exploratory factor analysis. Multiple logistic regression analysis was performed with physician attributes, awareness of ASD as a disorder or personality, and the three extracted factors as explanatory variables; diagnosis disclosure was the dependent variable. The patient age group and only one of the three factors (i.e., “factor related to readiness to accept diagnosis”) showed a significant association with disclosure of the diagnosis to the individual. Items included in the “factor related to readiness to accept diagnosis” were as follows: the degree of parental understanding, relationship of the patient with their parents/physician, agreement in opinion between parents, parental consent, “sufficient” patient understanding, symptom stabilization, and a guarantee of sufficient time required to explain the diagnosis to the patient CONCLUSION: In clinical settings, disclosing an ASD diagnosis with the consideration of patient/parent readiness toward accepting the diagnosis could help to guide physicians in determining an ideal timing for disclosure. Future studies are needed to establish detailed and concrete guidelines regarding disclosure of an ASD diagnosis to patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13030-022-00247-0.
format Online
Article
Text
id pubmed-9391641
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93916412022-08-21 Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study Sato, Hiroyuki Fujita, Misao Tsuchiya, Atsushi Hatta, Taichi Mori, Katsumi Nakazawa, Eisuke Takimoto, Yoshiyuki Akabayashi, Akira Biopsychosoc Med Research BACKGROUND: With a recent increase in the prevalence of autism spectrum disorder (ASD), an important issue has emerged in clinical practice regarding when and how patients themselves should be given explanations following a diagnosis of ASD. The clinical guidelines of the UK National Institute for Health and Care Excellence state that children diagnosed with ASD should receive an explanation about what ASD is and how it affects their development and functioning—“if appropriate”. However, the guidelines do not provide any specifics regarding what constitutes “appropriate” situations METHODS: We conducted an anonymous self-administered postal questionnaire survey targeting all members of the Japanese Society for Child and Adolescent Psychiatry (n=1,995). The analysis included only physicians who had newly diagnosed pediatric patients with ASD in the past year. We imposed a limit of one year because diagnoses further back than that are difficult to recall; in other words, this would enhance the recall bias RESULTS: The recovery rate was 30.8%, and the rate of diagnosis disclosure to patients themselves without intellectual disability was 15.3%. We asked 361 physicians who responded that “deciding on a case-by-case basis” was the ideal way to disclose an ASD diagnosis about 20 items prioritized by physicians at the time of diagnosis disclosure and extracted three factors through exploratory factor analysis. Multiple logistic regression analysis was performed with physician attributes, awareness of ASD as a disorder or personality, and the three extracted factors as explanatory variables; diagnosis disclosure was the dependent variable. The patient age group and only one of the three factors (i.e., “factor related to readiness to accept diagnosis”) showed a significant association with disclosure of the diagnosis to the individual. Items included in the “factor related to readiness to accept diagnosis” were as follows: the degree of parental understanding, relationship of the patient with their parents/physician, agreement in opinion between parents, parental consent, “sufficient” patient understanding, symptom stabilization, and a guarantee of sufficient time required to explain the diagnosis to the patient CONCLUSION: In clinical settings, disclosing an ASD diagnosis with the consideration of patient/parent readiness toward accepting the diagnosis could help to guide physicians in determining an ideal timing for disclosure. Future studies are needed to establish detailed and concrete guidelines regarding disclosure of an ASD diagnosis to patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13030-022-00247-0. BioMed Central 2022-08-20 /pmc/articles/PMC9391641/ /pubmed/35987775 http://dx.doi.org/10.1186/s13030-022-00247-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sato, Hiroyuki
Fujita, Misao
Tsuchiya, Atsushi
Hatta, Taichi
Mori, Katsumi
Nakazawa, Eisuke
Takimoto, Yoshiyuki
Akabayashi, Akira
Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study
title Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study
title_full Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study
title_fullStr Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study
title_full_unstemmed Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study
title_short Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study
title_sort disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in japan in early diagnostic stages and associated factors: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391641/
https://www.ncbi.nlm.nih.gov/pubmed/35987775
http://dx.doi.org/10.1186/s13030-022-00247-0
work_keys_str_mv AT satohiroyuki disclosingadiagnosisofautismspectrumdisorderwithoutintellectualdisabilitytopediatricpatientsinjapaninearlydiagnosticstagesandassociatedfactorsacrosssectionalstudy
AT fujitamisao disclosingadiagnosisofautismspectrumdisorderwithoutintellectualdisabilitytopediatricpatientsinjapaninearlydiagnosticstagesandassociatedfactorsacrosssectionalstudy
AT tsuchiyaatsushi disclosingadiagnosisofautismspectrumdisorderwithoutintellectualdisabilitytopediatricpatientsinjapaninearlydiagnosticstagesandassociatedfactorsacrosssectionalstudy
AT hattataichi disclosingadiagnosisofautismspectrumdisorderwithoutintellectualdisabilitytopediatricpatientsinjapaninearlydiagnosticstagesandassociatedfactorsacrosssectionalstudy
AT morikatsumi disclosingadiagnosisofautismspectrumdisorderwithoutintellectualdisabilitytopediatricpatientsinjapaninearlydiagnosticstagesandassociatedfactorsacrosssectionalstudy
AT nakazawaeisuke disclosingadiagnosisofautismspectrumdisorderwithoutintellectualdisabilitytopediatricpatientsinjapaninearlydiagnosticstagesandassociatedfactorsacrosssectionalstudy
AT takimotoyoshiyuki disclosingadiagnosisofautismspectrumdisorderwithoutintellectualdisabilitytopediatricpatientsinjapaninearlydiagnosticstagesandassociatedfactorsacrosssectionalstudy
AT akabayashiakira disclosingadiagnosisofautismspectrumdisorderwithoutintellectualdisabilitytopediatricpatientsinjapaninearlydiagnosticstagesandassociatedfactorsacrosssectionalstudy